The IBD 50 index remains under pressure for the third straight month, while AngloGold Ashanti (AU) confirms a failed breakout, shedding 10% since its August peak and triggering a technical sell signal.
The IBD 50 index is on track for a third consecutive monthly decline, indicating persistent weakness among leading stocks.
AngloGold Ashanti broke out above a 113.30 buy point but has since fallen 10% and triggered a sell signal, reflecting a failed breakout with negative momentum.
The IBD 50 index faces a third consecutive monthly decline, signaling broader weakness among top-tier growth stocks. AngloGold Ashanti (AU) has officially triggered a sell signal after failing to sustain momentum following its August breakout, dropping 10% from its recent highs.
The IBD 50 tracks top-performing growth stocks, and its consistent decline suggests a lack of momentum and broader weakness among leading market participants.
The stock triggered a sell signal after falling 10% from its August 20 breakout point of 113.30, indicating a failed technical setup.